RecruitingNot applicableNCT07045194

Virtue® SAB in the Treatment of Coronary ISR Trial

Studying Cold agglutinin disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Orchestra BioMed, Inc
Principal Investigator
Dean Kereiakes, MD
Lindner Center for Research at Christ Hospital
Intervention
Virtue Sirolimus AngioInfusion Balloon(device)
Enrollment
740 target
Eligibility
18 years · All sexes
Timeline
2025 – 2032

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07045194 on ClinicalTrials.gov

Other trials for Cold agglutinin disease

Additional recruiting or active studies for the same condition.

See all trials for Cold agglutinin disease →

← Back to all trials